Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Midsona Interim / Quarterly Report 2022

Jul 20, 2022

3078_ir_2022-07-20_ee42590c-c0d0-4a3a-a464-472de0206a2d.pdf

Interim / Quarterly Report

Open in viewer

Opens in your device viewer

INTERIM REPORT JANUARY–JUNE 2022

Favourable sales trend for the quarter

April–June 2022 (second quarter) January–June 2022 (six months)

  • Net sales amounted to SEK 956 million (903).
  • EBITDA, before items affecting comparability amounted to SEK 34 million (78), corresponding to a margin of 3.6 percent (8.6) and EBITDA amounted to SEK 28 million (89).
  • Operating profit, before items affecting comparability, amounted to SEK –7 million (39), corresponding to a margin of –0.7 percent (4.3) and operating profit amounted to SEK –13 million (42).
  • Profit for the period amounted to SEK –20 million (24), corresponding to earnings per share of SEK –0.28 (0.37) before and after dilution.
  • Cash flow from operating activities amounted to SEK 54 million (–29).
  • A restructuring programme was adopted to strengthen competitiveness, with the cost base being reduced by SEK 40 million on an annual basis. Restructuring expenses of SEK 6 million were charged against profit for the period.

  • Net sales amounted to SEK 1,928 million (1,868).

  • EBITDA, before items affecting comparability, amounted to SEK 96 million (172), corresponding to a margin of 5.0 percent (9.2) and EBITDA amounted to SEK 90 million (181).
  • Operating profit, before items affecting comparability, amounted to SEK 15 million (95), corresponding to a margin of 0.8 percent (5.1) and operating profit amounted to SEK 9 million (96).
  • Profit for the period amounted to SEK –8 million (57), corresponding to earnings per share of SEK –0.11 (0.88) before dilution and SEK –0.11 (0.87) after dilution.
  • Cash flow from operating activities amounted to SEK 46 million (–48).
Key figures, Group1 Apr–Jun
2022
Apr–Jun
2021
Jan–Jun
2022
Jan–June
2021
Rolling
12 months
Full year
2021
Net sales growth, % 5.9 5.1 3.2 3.5 1.6 1.7
Gross margin, before items affecting comparability, % 23.6 28.3 24.9 28.4 25.3 27.0
Gross margin, % 23.5 28.5 24.8 28.5 25.1 26.9
EBITDA-margin, before items affecting comparability, % 3.6 8.6 5.0 9.2 6.0 8.3
EBITDA margin, % 2.9 9.9 4.7 9.7 6.2 8.7
Operating margin, before items affecting comparability, % –0.7 4.3 0.8 5.1 2.0 4.2
Operating margin,% –1.4 4.7 0.5 5.1 1.9 4.3
Profit margin, % –2.8 3.3 –0.7 3.9 0.8 3.0
Return on capital employed, % 2.8 4.1
Net debt, SEK million 1,452 1,716 1,452 1,716 1,452 1,436
Net debt / Adjusted EBITDA, multiple 6.2 4.4
Equity/assets ratio, % 54.0 45.0 54.0 45.0 54.0 54.4
Free cash flow, SEK million 53 –35 38 –61 5 –94

1 Midsona presents certain financial measures in the Interim Report that are not defined under IFRS. For definitions and checks against IFRS, please refer to pages 18–19 of this interim report and to pages 184–188 in the 2021 Annual Report.

Note:

This is information such that Midsona AB (publ) is required to publish under the EU Market Abuse Regulation and the Securities Market Act. This Interim Report was submitted under the auspices of Peter Åsberg and Max Bokander for publication on 20 July 2022 at 8:00 a.m. CEST.

For further information

Peter Åsberg, CEO +46 730 26 16 32 Max Bokander, CFO +46 708 65 13 64

Peter Åsberg, President and CEO

QUARTER 2 SEK 956 million

Net sales

SEK 34 million

EBITDA, before items affecting comparability

3.6 percent

EBITDA-margin, before items affecting comparability

Comment by the CEO

The second quarter remained challenging and was characterised by increasing inflationary pressures. At the same time, we perceived favourable demand for our products and we anticipate continued strong consumer interest in healthy choices. To meet the exceptional level of cost inflation, we are implementing a number of measures with the ambition of fully offsetting our increased costs.

Organic growth bears witness to favourable demand

Sales for the quarter amounted to SEK 956 million (903), for us serving as testament that consumers want to continue eating healthily and are prepared to pay for it. We saw a continued strong trend for our own conventional brands, as well as for our consumer health brands, while our sales of organic products, which were very strong during the pandemic, had a weaker development. In general, our market analysis, shared by independent market analysts, is that consumers will continue to prioritise healthy food.

Continued price increases on all input goods

The war in Ukraine, transport problems and unfavourable exchange rate developments in the first half of the year led to shortages and continued sharp price increases on virtually all input goods. Although price increases were implemented as planned, further cost inflation in the second quarter was so high that our earnings for the quarter deteriorated compared with the corresponding period last year, despite increased sales and cost-saving measures.

Our own price increases generally well received

As we aim to fully offset cost inflation by passing on cost increases to the next level as quickly as possible, we have announced new price increases. A number of these have already taken, or will take place, during July and will be followed by further price increases later in the current quarter. Our price increases have generally been well received because the causes of the cost inflation are well known.

Difficult to predict continued cost trend

Forecasting the continued cost trend for input goods is difficult and the volatility in both commodity prices and currencies (USD and EUR in particular) remains a challenge. Although many prices continue to rise, the increase is not as dramatic as previously. Naturally, the price situation will be determined largely by the results of the year's harvests, which we are monitoring closely.

Full focus on cost control, launched programme progressing as planned

To strengthen earnings, we launched a restructuring programme early in the second quarter, aimed at reducing costs by SEK 40 million annually. The programme is progressing as planned and, during the quarter, resulted in a reduction in the number of employees in administrative functions by 5 percent. We have also identified and implemented additional cost savings beyond the programme already announced.

Strengthened supply chain and strong cash flow

During the quarter, favourable effects were achieved from the measures implemented in the first half of the year with the purpose of improving the supply chain and enhancing reliability in the supply of goods. We have, for example, taken delivery well in advance of raw materials (dried fruit and nuts) for the peak Christmas season, which was not the case last year, entailing additional expense for purchasing raw materials on the spot market. This year, our strengthened supply chain means we have significantly better planning for the key Christmas season. This good planning has led, however, to more capital being tied up in inventories. Nonetheless, free cash flow for the quarter was relatively strong at SEK 53 million (–35).

We take a confident view of the future

On the whole, we are fully focused on strengthening our earnings and are pleased that our sales have been stable a good sign that interest in healthy food remains high. We see no signs of weakened demand for our products. Consumers are making sustainable choices, regardless of higher prices, as is reflected by our price increases generally being accepted well and achieving a gradual impact. We look to the future with confidence. The strong underlying consumer trend for sustainable and plant-based products remains.

Peter Åsberg President and CEO

Financial information – Group

April–June

Net sales

Net sales amounted to SEK 956 million (903), an increase of 5.9 percent. The organic change in net sales was 0.4 percent, while structural changes contributed 3.0 percent and exchange rate changes 2.5 percent. For the Group's own brands, the organic sales growth was –2.3 percent. On the whole, the Group showed organic growth, driven by a favourable sales trend for its own brands in the healthfoods and consumer health products categories, as well as for licensed brands and contract manufacturing. The Group's own brands in the organic products category faced continued challenges, with a weak sales trend in most geographical markets. The supply chain remained under considerable pressure with significantly longer lead times for deliveries of raw materials, packaging materials and finished goods due to the global transport situation. Through good planning and foresight, delivery capacity could be maintained reasonably well.

Gross profit

Gross profit amounted to SEK 225 million (257) and gross profit, before items affecting comparability, amounted to SEK 226 million (256), corresponding to a margin of 23.6 percent (28.3). The negative margin trend was driven vigorously by continued inflationary pressure, causing higher prices for input goods, finished goods, energy and transport, that have yet to be offset through price increases at the next level. Price increases were implemented as planned, based on notifications sent to customers in the preceding quarter, although these were insufficient to offset the accelerating broader cost inflation. There was considerable volatility in the EUR and USD, currencies used by the Group to purchase most of its raw materials and finished goods, which affected the margin trend in a negative direction. The product mix was also unfavourable with a larger proportion of sales of contract-manufactured products. New price increases to customers were announced that will impact gross profit in the third quarter. The objective is to restore the margin, as swiftly as possible, in the second half of 2022.

Operating profit

Operating profit amounted to SEK –13 million (profit 42) and operating profit, before items affecting comparability, amounted to SEK –7 million (39), corresponding to a margin of –0.7 percent (4.3). Amortisation and depreciation for the period amounted to SEK 41 million (39), divided between SEK 12 million (12) in amortisation of intangible assets and SEK 29 million (27) in depreciation of tangible assets. EBITDA amounted to SEK 28 million (89) and EBITDA, before items affecting comparability, amounted to SEK 34 million (78), corresponding to a margin of 3.6 percent (8.6). The EBITDA margin decreased essentially as a consequence of weak development in the gross margin. The Group's cost control and cost awareness were good and the period was characterised by work on the restructuring programme initiated with the aim of reducing the cost base by SEK 40 million annually. Restructuring expenses of SEK 6 million were charged against profit for the period, with the

programme taking effect as planned and with some savings even being achieved during the period. EBITDA was also affected by negative operating translation differences, which were partially offset by a minor capital gain on divestments of fixed assets.

Items affecting comparability

Operating profit included items affecting comparability of SEK –6 million (3), comprising restructuring costs. In the comparison period, items affecting comparability comprised a reassessed contingent purchase consideration of SEK 10 million, the reversed portion of a restructuring reserve of SEK 1 million and the impairment of an intangible asset by SEK 8 million.

Financial items

Net financial items amounted to an expense of SEK 14 million (12). Interest expenses for external loans to credit institutions amounted to SEK 11 million (8) and interest expenses attributable to leases were SEK 1 million (1). Net translation differences on financial receivables and liabilities in foreign currency were SEK –1 million (–1). Other financial items amounted to SEK –1 million (–2).

Profit for the period

Profit for the period amounted to SEK –20 million (24), corresponding to a loss per share of SEK –0.28 (0.37) before and after dilution. Tax on the profit for the period amounted to SEK 7 million (–6), of which current tax amounted to SEK 3 million (–3) and deferred tax amounted to SEK 4 million (–3). The effective tax rate was 27.4 percent (21.6).

Cash flow

Cash flow from operating activities amounted to SEK 54 million (–29), improving as a consequence of a stronger cash flow from changes in working capital, primarily due to increased operating liabilities. Capital remained tied up in inventories to a certain extent, related essentially to a customary build-up of inventory prior to the summer months, as well as deliveries of raw materials and input goods being moved forwards due to significantly increased transport lead times. Cash flow from investing activities amounted to SEK –4 million (–20) and comprised investments in tangible and intangible assets of SEK –11 million (–17), including an expansion investment in South Europe of SEK –3 million (–11), as well as a sale of tangible fixed assets for SEK 7 million, essentially comprising one individual property in South Europe. The comparison period also included the payment of contingent purchase consideration of SEK 3 million. Although the expansion investment in Spain has already been brought into operation, part of the investment has yet to be completed, and this is expected to occur in the fourth quarter of 2022. Free cash flow amounted to SEK 53 million (–35). Cash flow from financing activities was SEK –33 million (–11), consisting of SEK 12 million in loans raised (151), of which SEK 12 million in used overdraft facilities, SEK –30 million (–83) in loan repayments, and SEK –15 million (–15) in amortisations of lease liabilities. The comparative period also included paid dividends of SEK –42 million. Cash flow for the period amounted to SEK 17 million (–38).

January–June

Net sales

Net sales amounted to SEK 1,928 million (1,868), an increase of 3.2 percent. The organic change in net sales was –2.7 percent while structural changes contributed by 3.3 percent and exchange rate changes by 2.6 percent. For the Group's own brands, the organic sales growth was –3.3 percent. On the whole, the sales trend for comparable units within the Group declined, despite strong growth for our own brands in the healthfoods and consumer health products categories. For our own brands in the Organic products category, sales were weak. The removal of pandemic restrictions in society compared with the preceding year led to a changed consumption pattern with less household consumption and more restaurant visits, which generally disadvantaged the organic products category. The supply chain remained pressured with longer lead times for deliveries of raw materials, packaging materials and finished goods due to the global transport situation.

Gross profit

Gross profit amounted to SEK 479 million (532) and gross profit, before items affecting comparability, amounted to SEK 480 million (531), corresponding to a margin of 24.9 percent (28.4). The negative margin trend was driven strongly by continued inflationary pressure, with rising prices for finished gods, raw materials, input goods, energy and transport, which could not immediately be parried by price increases to customer, but that occur with a certain time lag. There was also considerable volatility in the EUR and USD, currencies used by the Group to purchase most of its raw materials and finished goods, which affected the margin trend in a negative direction. New price increases were both announced and implemented to customers in stages to offset the broad inflationary pressure to restore the margin as quickly as possible in the second half of 2022.

Operating profit

Operating profit amounted to SEK 9 million (96) and operating profit, before items affecting comparability, amounted to SEK 15 million (95), corresponding to a margin of 0.8 percent (5.1). Amortisation and depreciation for the period amounted to SEK 81 million (77), divided between SEK 24 million (23) in amortisation of intangible fixed assets and depreciation of SEK 57 million (54) on tangible fixed assets. Furthermore, in the comparison period, impairment of SEK 8 million was applied to intangible assets as the result of a product development project being discontinued. EBITDA amounted to SEK 90 million (181) and EBITDA, before items affecting comparability, amounted to SEK 96 million (172), corresponding to a margin of 5.0 percent (9.2). The EBITDA margin decreased, essentially as a consequence of lower business volumes for comparable units and a weak gross margin trend. Selective investments in own brands continued to be made. Cost control and cost awareness in the Group were good. A restructuring programme was initiated in the second quarter, as part of strengthening the Group's competitiveness.

Items affecting comparability

Operating profit included items affecting comparability of a SEK –6 million (1), comprising restructuring costs. In the comparison period, items affecting comparability comprised a reassessed contingent purchase consideration of SEK 10 million, the reversed portion of a restructuring reserve of SEK 1 million, the impairment of an intangible asset by SEK 8 million and acquisition-related expenses of SEK 2 million.

Financial items

Net financial items amounted to an expense of SEK 22 million (23). Interest expenses for external loans to credit institutions amounted to SEK 19 million (16) and interest expenses attributable to leases were SEK 2 million (2). Net translation differences on financial

receivables and liabilities in foreign currency were SEK 1 million (–2). Other financial items amounted to SEK –2 million (–3).

Profit for the period

Profit for the period amounted to SEK –8 million (57), corresponding to earnings per share of SEK –0.11 (0.88) before dilution and SEK –0.11 (0.87) after dilution. Tax on the profit for the period amounted to income of SEK 5 million (–16), of which current tax amounted to SEK –3 million (–11) and deferred tax amounted to SEK 8 million (–5). The effective tax rate was 40.3 percent (22.2).

Cash flow

Cash flow from operating activities amounted to SEK 46 million (–48) as a result of a stronger cash flow from changes in working capital. The improved change in working capital was primarily driven by a reduction in capital tied-up in inventories and increased operating liabilities. Cash flow from investing activities amounted to SEK –14 million (–35), consisting of investments in tangible and intangible fixed assets of SEK 21 million (32), of which an on-going expansion investment in South Europe accounted for SEK 6 million (19) and a divestment of fixed assets for SEK 7 million. The comparison period also included the payment of a contingent purchase consideration of SEK 3 million for acquisitions in previous years. Free cash flow amounted to SEK 38 million (–61). Cash flow from financing activities was SEK –19 million (–27), consisting of SEK 70 million in loans raised (151), of which SEK 64 million in used overdraft facilities, SEK –60 million (–106) in loan repayments, and SEK –29 million in amortisations of lease liabilities (–30). The comparative period also included paid dividends of SEK –42 million. Cash flow for the period amounted to SEK 13 million (–110).

Liquidity and financial position

Cash and equivalents amounted to SEK 64 million (86) and there were unused credit facilities of SEK 406 million (250) at the end of the period. Net debt amounted to SEK 1,452 million (1,716) and was SEK 1,464 million at the end of the preceding quarter. The ratio between net debt and adjusted EBITDA on a rolling 12-month basis was a multiple of 6.2 (4.9) and at the end of the preceding quarter it was a multiple of 5.1. Equity amounted to SEK 2,931 million (2,321) and was SEK 2,928 million at the end of the preceding quarter. The changes consisted of profit for the period of SEK –20 million and exchange rate differences of SEK 23 million on the translation of foreign operations. The equity/assets ratio was 54.0 percent (45.0) at the end of the period.

During the quarter, the Happy Bio brand in France launched Biscuit and Cracker snacks.

Division Nordics

68% Percentage net sales in the Group2

Division Nordics1 Apr–Jun
2022
Apr–Jun
2021
Jan–Jun
2022
Jan–Jun
2021
Rolling
12-month
Full year
2021
Net sales 657 606 1,314 1,265 2,660 2,611
Gross profit 185 195 384 405 780 800
Gross margin, % 28.2 32.2 29.3 32.0 29.3 30.7
EBITDA 39 56 92 129 225 263
EBITDA margin, % 5.9 9.3 6.9 10.2 8.5 10.1

1 Earnings and margin measurements refer to before items affecting comparability unless otherwise stated.

April–June

Net sales

Net sales amounted to SEK 657 million (606), an increase of 8.3 percent, where the organic change in net sales was 1.7 percent. The organic change in external product sales of own brands was –0.7 percent. The sales trend was generally good, driven by strong growth for our own brands in the healthfoods and consumer health products categories, such as Friggs, Earth Control, Gainomax and Swebar. Even the licensed brand portfolio showed sales growth, including strong sales of seasonal products ahead of the summer months. On the other hand, sales of our own brands in the organic products category experienced a weaker trend.

Gross profit

Gross profit amounted to SEK 185 million (195), corresponding to a margin of 28.2 percent (32.2). The negative margin trend was driven strongly by continued inflationary pressure, causing higher prices for finished goods, raw materials, input goods, energy and transport, that have yet to be offset through price increases at the next level. In addition, an unfavourable exchange rate trend for both the EUR and USD contributed significantly to the negative margin trend, as a significant proportion of raw materials for the Danish operations are purchased in USD and a significant proportion of finished goods are purchased for the Swedish and Norwegian operations in EUR. New price increases were announced to customers as a consequence of the increased inflationary pressure, impacting gross profit in the third quarter.

EBITDA

EBITDA amounted to SEK 39 milllion (56), corresponding to a margin of 5.9 percent (9.3), as a consequence of a lower gross profit. In addition, EBITDA was affected by negative operating translation differences. Realised savings from restructuring programmes and good cost control offset lower gross profit and the lower gross margin only to some extent.

January–June

Net sales

Net sales amounted to SEK 1,314 million (1,265), an increase of 3.9 percent, where the organic change in net sales was –3.3 percent. The organic change in external product sales of own brands was –3.5 percent. On the whole, the sales trend declined despite strong growth among own brands in the healthfoods and consumer health products categories. However, our own brands in the organic products category faced continued challenges with a generally weak sales trend.

Gross profit

Gross profit amounted to SEK 384 million (405), corresponding to a margin of 29.3 percent (32.0). The negative margin trend was driven strongly by continued inflationary pressure, with rising prices for finished goods, raw materials, input goods, energy and transport, which could not immediately be parried by price increases to customer, but that occur with a certain time lag. In addition, an unfavourable exchange rate trend for both the EUR and USD contributed strongly to the negative margin trend. New price increases were announced to customers and were implemented in turns to offset broad inflationary pressure and to restore the margin moving forwards.

EBITDA

EBITDA amounted to SEK 92 milllion (129), corresponding to a margin of 6.9 percent (10.2), as a consequence of a lower gross profit. In addition, EBITDA was affected by negative operating translation differences, which were positive in the comparison period. Withdrawals of cost synergies from acquisitions, realised savings from the restructuring programme and good cost control only compensated to a certain extent for the lower gross profit and the lower gross margin.

Quarter Quarter Net sales EBITDA, before items affecting 70 percent comparability 2 Percentage of own brands, income –0.7 percent2 Organic growth of own brands3 0 200 400 600 800 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 0 700 1400 2100 2800 SEK m SEK m 0 20 40 60 80 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 0 80 160 240 320 SEK m SEK m Net sales per sales channel Q2, 2022 0 125 250 375 500 Group-internal sales Others Other specialist retail Healthfood stores Food Service Grocery trade Pharmacies SEK m 2 For Q2, 2022

Rolling, 12 months

3 For external product sales

Rolling, 12 months

Q2, 2021

Division North Europe 22% Percentage net sales

in the Group2

Division North Europe1 Apr–Jun
2022
Apr–Jun
2021
Jan–Jun
2022
Jan–Jun
2021
Rolling
12-month
Full year
2021
Net sales 215 204 437 428 840 831
Gross profit 31 39 66 81 128 143
Gross margin, % 14.6 18.9 15.1 18.9 15.2 17.2
EBITDA 6 19 15 37 28 50
EBITDA margin, % 3.0 9.2 3.5 8.7 3.4 6.1

1 Earnings and margin measurements refer to before items affecting comparability unless otherwise stated.

April–June

Net sales

Net sales amounted to SEK 215 million (204), an increase of 5.2 percent, where the organic change in net sales was 1.7 percent. The organic change for own brands in external product sales was 1.3 percent. Sales development as a whole was stable, driven by good sales growth for our own brands. In particular, sales volumes increased to the food service sales channel. Fewer pandemic restrictions in society compared with the previous year led to a change in consumption patterns with less household consumption and more restaurant visits, which contributed to the strong sales growth for food service.

Gross profit

Gross profit amounted to SEK 31 million (39), corresponding to a margin of 14.6 percent (18.9). The negative margin trend was driven strongly by an unfavourable product mix and the continued inflationary pressure, causing higher prices for raw materials, input goods, energy and transport, that have yet to be offset through price increases at the next level. In addition, an unfavourable exchange rate trend for the USD contributed to the negative margin trend, as a considerable portion of raw materials are purchased in USD. Implemented price increases were not enough to cover the increased costs that the continued inflationary pressure entailed, which is why new price increases were announced to customers with an impact on gross profit in the third quarter.

EBITDA

EBITDA amounted to SEK 6 million (19), corresponding to a margin of 3.0 percent (9.2) and decreased essentially as a consequence of the lower gross profit. In addition, sales costs were higher due to, among other things, higher costs for shipping.

January–June

Net sales

Net sales amounted to SEK 437 million (428), an increase of 2.1 percent, where the organic change in net sales was –1.3 percent. The organic change for own brands in external product sales was 1.1 percent. The sales trend was relatively stable with sales growth in our own brands. Sales volumes to the food service sales channel had strong growth. Fewer pandemic restrictions in society compared with the previous year led to a changed consumption pattern with less household consumption and more restaurant visits, which contributed strongly to sales growth in food service, partly at the expense of a slightly weaker sales trend to the grocery trade and healthfood stores.

Gross profit

Gross profit amounted to SEK 66 million (81), corresponding to a margin of 15.1 percent (18.9). The negative margin trend was driven strongly by an unfavourable product mix and the continued inflationary pressure, with rising prices for raw materials, input goods, energy and transport, which could not immediately be parried by price increases to customers, but that occur with a certain time lag. New price increases were announced to customers and were implemented in turns to offset broad inflationary pressure and to restore the margin moving forwards. In addition, an unfavourable exchange rate trend for the USD contributed to the negative margin trend, as a considerable portion of raw materials are purchased in USD.

EBITDA

EBITDA amounted to SEK 15 million (37), corresponding to a margin of 3.5 percent (8.7) and decreased essentially as a consequence of the lower gross profit. In addition, sales costs increased to some extent as a result of higher costs for shipping.

Division South Europe Percentage net sales

in the Group2 10%

Division South Europe1 Apr–Jun
2022
Apr–Jun
2021
Jan–Jun
2022
Jan–Jun
2021
Rolling
12-month
Full year
2021
Net sales 96 100 196 197 369 369
Gross profit 10 24 31 47 60 77
Gross margin, % 9.9 23.4 15.5 23.8 16.4 20.8
EBITDA –5 10 1 19 8 26
EBITDA margin, % –5.5 10.0 0.6 9.7 2.2 7.0

1 Earnings and margin measurements refer to before items affecting comparability unless otherwise stated.

April–June

Net sales

Net sales amounted to SEK 96 million (100), a decrease of 4.8 percent, where the organic change in net sales was –7.8 percent. The organic change for own brands in external product sales was –17.0 percent. The sales trend for own brands was generally weak as a result of the ongoing structural change where the operations' largest sales channel, healthfood stores, is losing customers who are, to a greater extent, choosing to make their purchases from the grocery trade. There were also shortages of certain raw materials, which led to a certain loss of sales. Sales to the grocery trade showed good growth, despite a planned delivery interruption for the Happy Bio brand, as warehousing and distribution were brought under own management. In addition, newly rolled-out business volumes of contracted products made a strong contribution to the positive trend in the grocery trade.

Gross profit

Gross profit amounted to SEK 10 million (24), corresponding to a margin of 9.9 percent (23.4). The negative margin trend was driven strongly by an unfavourable product mix and the continued inflationary pressure, causing higher prices for raw materials, input goods, energy and transport, that have yet to be offset through price increases at the next level. The margin was also affected by temporary additional expenses for bringing warehousing and distribution for the Happy Bio brand under own management. Capacity utilisation at the recently opened production facility for plant-based meat alternatives remained low, which contributed to the weak margin trend. New price increases were announced to customers as a consequence of the increased inflationary pressure, impacting gross profit in the next quarter.

EBITDA

EBITDA amounted to SEK –5 million (10), corresponding to a negative margin of 5.5 percent (positive 10.0) and decreased as a consequence of the lower gross profit. Selling expenses were also higher due to investments in an external sales force to drive sales growth in the grocery trade. A property in Spain, where operations were conducted until July 2021, was divested, realising a minor capital gain.

January–June

Net sales

Net sales amounted to SEK 196 million (197), a decrease of 0.2 percent, where the organic change in net sales was –3.5 percent. The organic change in external product sales of own brands was –9.4 percent. Sales as a whole declined due to weak development in most of our own brands. Lower sales volumes to healthfood stores could not fully be offset by correspondingly higher volumes to the grocery trade. The French market for organic products has, in particular, been shifting for some time now, resulting in lower sales volumes to healthfood stores, in favor of sales to the grocery trade. On the whole, the Happy Bio brand experienced a stable sales trend over the period, despite a decline in sales in June due both to a planned delivery interruption when switching to a new logistics solution, as well as to goods shortages. Distribution of contract-manufactured products to the grocery trade increased due to new customer agreements.

Gross profit

Gross profit amounted to SEK 31 million (47), corresponding to a margin of 15.5 percent (23.8). The negative margin trend was driven strongly by continued inflationary pressure, with rising prices for raw materials, input goods, energy and transport, which could not immediately be parried by price increases to customer, but that occur with a certain time lag. New price increases were announced to customers and were implemented in turns to offset broad inflationary pressure and to restore the margin moving forwards. In the French market, however, the price adjustment process is more regulated and price adjustments take longer to implement there. The margin trend was also affected by an unfavourable product mix, as well as by some temporary additional expenses. Capacity utilisation at the recently opened facility for plant-based meat alternatives remained low, which contributed to the weak margin trend.

EBITDA

Quarter Rolling, 12 months

SEK m SEK m

Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021

–20 –10

0,0 2,5 5,0 7,5 10,0

–5,0 –2,5 EBITDA amounted to SEK 1 million (19), corresponding to a margin of 0.6 percent (9.7) and decreased essentially as a consequence of the lower gross profit.

Net sales per sales channel

Group-internal sales Others

Other specialist retail Healthfood stores Food Service Grocery trade Pharmacies

Percentage of own brands, income

–17 percent2

2 For Q2, 2022 3 For external product sales Q2, 2022 Q2, 2021

0 15 30 45 60

SEK m

Other information

Seasonal variations

Sales and earnings are affected to some extent by seasonal variations. Sales in the first and second quarter are affected by Easter week, depending on which quarter it occurs in. Easter week does not favour sales for the Group's product groups. Warm summer months normally entail lower sales for most product groups as the consumers prioritise different consumption. The second quarter of the year is usually the Group's weakest in terms of sales and profit. Sales are generally higher in the fourth quarter than in the first three quarters, which is mainly due to seasonally high deliveries of dried fruits and nuts prior to the Christmas holidays.

Parent Company

Net sales amounted to SEK 32 million (34), and related primarily to invoicing of services provided internally within the Group. Profit before tax amounted to a loss of SEK 14 million (loss 6). Operating profit amounted to a loss of SEK 12 million (11). Net financial items amounted to an expense of SEK 2 million (income 5), with the comparison period including a dividend of SEK 1 million. Profit before tax amounted to a loss of SEK 14 million (loss 6).

Cash and cash equivalents, including unutilised credit facilities, amounted to SEK 406 million (280). Borrowing from credit institutions was SEK 1,315 million (1,523) at the end of the period. On the balance sheet date, there were 16 employees (17).

Closely-related parties

There were no significant related party transactions during the period January – June. Also see Note 33 Related parties on page 160 in the 2021 Annual Report for a description of the Group's and the Parent Company's related party transactions.

Risks and uncertainties

In its operations, the Group is subject to operational, market, financial and sustainability risks that may affect profits to a greater or lesser extent. In the first quarter of 2022, the security policy situation in Europe changed drastically with Russia's invasion of Ukraine. Midsona had no material direct customer or supplier exposure in the countries concerned – Ukraine, Russia and Belarus, but was strongly indirectly affected by the accelerated inflationary pressures with gradually rising prices on commodities, completed goods, packaging materials, energy and transport as a result of the Ukraine crisis. In addition, Ukraine is a major exporter of important cereals, such as wheat, maize and sunflower seeds, which are included as ingredients in some of the Group's finished products. Logistics problems in transporting last year's grain crops out of the country rapidly pushed up world market prices, severely impacting already hard-pressed subcontractors. Being theatres of war, large areas of arable land were not sown in the spring, likely leading to later shortages and further driving up already high world market prices for certain cereals. The impact of the current year's harvest on key raw materials, including chia and sesame seeds, also remains uncertain due to prevailing climate-related risks. The global transport situation worsened as a consequence partly of Asian ports being closed because of the pandemic, as well as the security policy situation in Europe, which together exerted further pressure on the supply chain, with delivery delays and shortages as a result.

Because lead times for certain transports have more than doubled recently, orders are generally being placed earlier. In addition, greater reserve inventories of crucial raw materials and finished goods are being maintained. An overall assessment results in the Ukraine crisis continuing to negatively affect the Group's earnings and financial position in the short term as there is a built-in delay between announced price increases and their effect on gross profit being felt. This lead time is usually longer for contract manufacturing assignments, which constitute approximately 15 percent of the Group's revenues. Volatility in commodity prices, prices for input goods and exchange rates presents an ongoing challenge. Although many prices are expected to continue rising, the increase will be less dramatic than previously. The price situation for important raw materials will largely be determined by this year's harvest results, which are closely monitored. Policy and reference interest rates will most likely continue rising to counteract the high rate of inflation, entailing higher interest expenses on the Group's financing. Beyond that, the assessment is that no new significant risks or uncertainties have arisen. For a detailed account of risks and uncertainty factors, please see the section Risks and risk management on pages 116–125 and Note 31 Financial risk management on pages 158–160 in the 2021 Annual Report.

Significant events January–June

Customer agreement

A contract manufacturing agreement was signed with Mercadona, Spain's largest grocery trade chain, for deliveries of plant-based meat alternatives. It is estimated that the customer agreement will generate about SEK 30–40 million in net sales annually, with production taking place at the production facility in Spain.

Prestigious appointment for supplier engagement

The global environmental initiative CDP named Midsona a Supplier Engagement Leader for its commitment along the entire supply chain. The award means that Midsona is one of the best companies globally when it comes to climate change strategy and leadership.

Change in Group Management

In addition to her current role, Director Legal, Tora Molander, has been appointed Risk and Sustainability Manager for the Midsona Group and is a member of Group Management as of 1 April 2022.

Security situation in Ukraine

Midsona has no material direct customer or supplier exposure in Ukraine, Russia or Belarus. However, the events in Ukraine have indirectly had major negative consequences for the Group through gradually rising prices for finished goods, raw materials, input goods, transport and energy, which could not immediately be parried by price increases to customers. The Ukraine crisis has also caused increased turmoil in financial markets, resulting in, for example, high volatility in major currency rates and rising market interest rates. As Ukraine is a major grain exporter, the situation will likely cause both shortages in, and rising world market prices for, certain commodities. Midsona is monitoring the Ukraine crisis meticulously and will implement the required measures as necessary.

Restructuring programme

In April, a decision was made to implement a restructuring programme as a measure to strengthen competitiveness. The ambition is to reduce the cost base by SEK 40 million on an annual basis through structural changes, including staff cutbacks, as far as possible by terminating contracts with hired staff and through natural staff redundancies.

Award

Alongside two other companies, Midsona won the 2022 Symbios award, which recognises Swedish companies that successfully combine responsible behaviour with profitable growth.

Distribution agreement

Midsona's distribution agreement for the Compeed, EllaOne and Norlevo brands in the Nordic market has been terminated by the new owner Perrigo as of 31 December 2022, as they intend to coordinate in-house distribution with their other products in the European market. The sales assignment accounted for about 3 percent of the Group's net sales in 2021 with a below-average gross margin. After deducting expenses and certain cost savings, the effect on profit is expected to be limited.

The Board of Directors and the CEO provide their assurance that this interim report gives a true and fair view of the operations, positions and results of the Parent Company and the Group, and describes significant risks and uncertainties faced by the Parent Company and the companies included in the Group.

Malmö, 20 July 2022 Midsona AB (publ)

Ola Erici CHAIRMAN OF THE BOARD

Heli Arantola BOARD MEMBER

Sandra Kottenauer BOARD MEMBER

Jari Latvanen BOARD MEMBER

Henrik Stenqvist BOARD MEMBER

Peter Wahlberg BOARD MEMBER

Johan Wester BOARD MEMBER

Peter Åsberg

President and CEO

Review by auditor

This interim report was not subject to review by company's auditors.

Financial statements

Summary consolidated income statement

SEK million Note Apr–Jun
2022
Apr–Jun
2021
Jan–Jun
2022
Jan–Jun
2021
Rolling
12-month
Full year
2021
Net sales 3.4 956 903 1,928 1,868 3,833 3,773
Expenses for goods sold –731 –646 –1,449 –1,336 –2,871 –2,758
Gross profit 225 257 479 532 962 1,015
Selling expenses –162 –155 –319 –306 –605 –592
Administrative expenses –76 –73 –150 –146 –293 –289
Other operating income 2 13 4 20 19 35
Other operating expenses –2 0 –5 –4 –9 –8
Operating profit 3 –13 42 9 96 74 161
Financial income 25 –5 35 2 44 11
Financial expenses –39 –7 –57 –25 –89 –57
Profit before tax –27 30 –13 73 29 115
Tax on profit for the period 7 –6 5 –16 –5 –26
Profit for the period –20 24 –8 57 24 89
Profit for the period is divided between:
Parent Company shareholders (SEK million) –20 24 –8 57 24 89
Earnings per share before dilution attributable to Parent Company shareholders
(SEK)
–0.28 0.37 –0.11 0.88 0.33 1.31
Earnings per share after dilution attributable to Parent Company shareholders
(SEK)
–0.28 0.37 –0.11 0.87 0.33 1.30

Summary consolidated statement of comprehensive income

SEK million Apr–Jun
2022
Apr–Jun
2021
Jan–Jun
2022
Jan–Jun
2021
Rolling
12-month
Full year
2021
Profit for the period –20 24 –8 57 24 89
Items that have or can be reallocated to profit for the period
Translation differences for the period on translation of foreign operations 23 –31 64 33 94 63
Other comprehensive income for the period 23 –31 64 33 94 63
Comprehensive income for the period 3 –7 56 90 118 152
Comprehensive income for the period is divided between:
Parent Company shareholders (SEK million) 3 –7 56 90 118 152

Norwegian brand Helios launched a series of organic muesli products in four new flavours.

Summary consolidated balance sheet

SEK million Note 30 Jun 2022 30 Jun 2021 31 Dec 2021
Intangible assets 3,411 3,275 3,364
Tangible assets 506 530 522
Non-current receivables 4 4 4
Deferred tax assets 98 93 91
Fixed assets 4,019 3,902 3,981
Inventories 845 730 783
Accounts receivable 408 374 403
Tax receivables 15 11 18
Other receivables 46 28 33
Prepaid expenses and accrued income 26 26 16
Cash and cash equivalents 64 86 53
Current assets 1,404
5
5,423
6
363
1,627
69
1,255 1,306
Assets 5,157 5,287
Share capital 326 363
Additional paid-up capital 1,168 1,627
Reserves ‒25 5
Profit brought forward, including profit for the period 872 852 880
Shareholders' equity 2,931 2,321 2,875
Non-current interest-bearing liabilities 1,283 1,592 1,314
Other non-current liabilities 11 14 11
Deferred tax liabilities 352 338 347
Non-current liabilities 1,646 1,944 1,672
Current interest-bearing liabilities 233 210 175
Accounts payable 372 397 342
Tax liabilities 9 3 15
Other current liabilities 41 98 41
Accrued expenses and deferred income 191 184 167
Current liabilities 846 892 740
Liabilities 5 2,492 2,836 2,412
Shareholders' equity and liabilities 5,423 5,157 5,287

Summary consolidated changes in shareholders' equity

SEK million Share
capital
Additional
paid-up capital
Reserves Profit brought
forward, incl. profit
for the period
Shareholders'
equity
Opening shareholders' equity 1 January 2021 325 1,169 –58 877 2,313
Profit for the period 57 57
Other comprehensive income for the period 33 33
Comprehensive income for the period 33 57 90
Completed issue of warrant programme, TO2017/2020 1 –1 0
Issue expenses, TO2017/2020 0 0
Dividend –82 –82
Transactions with the Group's owners 1 –1 –82 –82
Closing shareholders' equity 30 June 2021 326 1,168 –25 852 2,321
Opening shareholders' equity 1 July 2021 326 1,168 –25 852 2,321
Profit for the period 32 32
Other comprehensive income for the period 30 30
Comprehensive income for the period 30 32 62
New share issue 37 463 500
Issue expenses –6 –6
Premium paid in on issuing warrant programme, TO2021/2024 2 2
Dividend –4 –4
Transactions with the Group's owners 37 459 –4 492
Closing shareholders' equity, 31 Dec 2021 363 1,627 5 880 2,875
Opening shareholders' equity, 1 Jan 2022 363 1,627 5 880 2,875
Profit for the period –8 –8
Other comprehensive income for the period 64 64
Comprehensive income for the period 64 –8 56
Closing shareholders' equity, 30 June 2022 363 1,627 69 872 2,931

Summary consolidated cash flow statement

SEK million Apr–Jun
2022
Apr–Jun
2021
Jan–Jun
2022
Jan–Jun
2021
Rolling
12-month
Full year
2021
Profit before tax –27 30 –13 73 29 115
Adjustment for items not included in cash flow 48 30 94 61 174 141
Income tax paid 0 –5 –6 –7 –11 –12
Cash flow from operating activities before changes in working capital 21 55 75 127 192 244
Increase (–)/decrease (+) in inventories –29 –56 –39 –91 –72 –124
Increase (–)/decrease (+) in operating receivables –6 15 –17 –76 –21 –80
Increase (+)/decrease (–) in operating liabilities 68 –43 27 –8 –69 –104
Changes in working capital 33 –84 –29 –175 –162 –308
Cash flow from operating activities 54 –29 46 –48 30 –64
Acquisitions of companies or operations –3 –3 –111 –114
Acquisitions of intangible assets 0 –1 –1 –3 –3 –5
Acquisitions of tangible assets –11 –16 –20 –29 –45 –54
Divestments of tangible fixed assets 7 7 7
Change in financial assets 0 0 0 0 –2 –2
Cash flow from investing activities –4 –20 –14 –35 –154 –175
Cash flow after investing activities 50 –49 32 –83 –124 –239
New share issue 500 500
Issue expenses –6 –6
Premium paid in, warrant programme, TO2021/2024 2 2
Loans raised 12 151 70 151 210 291
Repayment of loans –30 –83 –60 –106 –503 –549
Amortisation of lease liabilities –15 –15 –29 –30 –57 –58
Dividend paid –42 –42 –44 –86
Cash flow from financing activities –33 11 –19 –27 102 94
Cash flow for the period 17 –38 13 –110 –22 –145
Cash and equivalents at beginning of period 53 123 53 195 86 195
Translation difference in cash and cash equivalents –6 1 –2 1 0 3
Cash and cash equivalents at end of the period 64 86 64 86 64 53

Summary income statement, Parent Company

SEK million Apr–Jun
2022
Apr–Jun
2021
Jan–Jun
2022
Jan–Jun
2021
Rolling
12-month
Full year
2021
Net sales 17 19 32 34 62 64
Administrative expenses –23 –25 –44 –45 –87 –88
Other operating income 0 0 0 0 0 0
Other operating expenses 0 0 0 0 0 0
Operating profit –6 –6 –12 –11 –25 –24
Result from participations in subsidiaries 1 1 2 3
Financial income 26 –5 52 23 83 54
Financial expenses –38 –3 –54 –19 –81 –46
Profit after financial items –18 –13 –14 –6 –21 –13
Allocations 26 26
Profit before tax –18 –13 –14 –6 5 13
Tax on profit for the period 0 0 0 0
Profit for the period1 –18 –13 –14 –6 5 13

1 Profit for the period and comprehensive income for the period are the same, as the Parent Company has no transactions that are reported in other comprehensive income.

Summary balance sheet, Parent Company

SEK million Note 30 Jun 2022 30 Jun 2021 31 Dec 2021
Intangible assets 47 54 51
Tangible assets 4 3 5
Participations in subsidiaries 2,553 2,547 2,535
Receivables from subsidiaries 1,361 1,148 1,321
Deferred tax assets 2 2 2
Financial assets 3,916 3,697 3,858
Fixed assets 3,967 3,754 3,914
Receivables from subsidiaries 138 17 117
Other receivables 14 16 12
Cash and bank balances 30 2
Current assets 152 63 131
Assets 5 4,119 3,817 4,045
Share capital 6 363 326 363
Statutory reserve 58 58 58
Profit brought forward, including profit for the period and other reserves 2,105 1,648 2,118
Shareholders' equity 2,526 2,032 2,539
Untaxed reserves 5 5
Liabilities to credit institutions 1,143 1,420 1,166
Other non-current liabilities 0 0
Non-current liabilities 1,143 1,420 1,166
Liabilities to credit institutions 172 103 107
Liabilities to subsidiaries 258 196 212
Other current liabilities 15 66 16
Current liabilities 445 365 335
Equity and liabilities 5 4,119 3,817 4,045

Notes to the financial statements

Note 1 | Accounting principles

With regard to the Group, this Interim Report has been prepared in accordance with IAS 34 Interim Financial Reporting and the Annual Accounts Act (ÅRL). In addition to being presented in the financial statements and their notes, disclosures in accordance with IAS 34.16A are also presented in other parts of the interim report. The Parent Company's accounts are prepared in accordance with the Annual Accounts Act (ÅRL) and recommendation RFR 2 Accounting for Legal Entities, from the Swedish Financial Reporting Board. The statements published by the Swedish Financial Reporting Board concerning listed companies are also applied, meaning that the Parent Company must apply all EU-approved IFRS and statements as far as possible within the framework of the Annual Accounts Act, the Pension Protection Act and taking the relationship between accounting and taxation into account.

In the interim report for January–June 2022, the same accounting principles and calculation methods were applied as in the last annual report issued for 2021 (Note 1 Accounting principles, pages 136–142). The new standards and the amendments and revisions to standards and new interpretations (IFRIC) that came into effect on 1 January 2022 had no significant impact on the Group's accounting for the period January–June 2022.

Reporting of cloud service events

IFRIC has published agenda decisions for how companies should report expenses in a Software-as-a-Service (SaaS) arrangement where access to

Note 2 | Significant estimates and assumptions

Preparing the financial statements in accordance with IFRS requires management to make estimates and assumptions that affect the application of the accounting principles and the reported amounts of assets, liabilities, income and expenses. The actual outcome may differ from these estimates and assumptions.

For a detailed account of the assessments made by management in the application of IFRS and that have a significant impact on the financial statesoftware is obtained via the cloud, and configuring and adapting such software is also achieved through a cloud-based service arrangement. The decisions clarify that companies may not capitalise expenditures attributable to the implementation of a cloud-based service arrangement if they do not have control over the application, and that expenses for the configuration and adaptation of software services in such a cloud-based service arrangement must in many cases be reported as an expense in the same period. The assessment of the period for which the services are obtained depends, however, on whether they are distinct in relation to the service of obtaining access to the software. If the services are judged to be distinct, the expense is reported in the same period as the services are performed. If the services are not deemed distinct, the expenses are reported as an expense in the same period as the company receives access to the software, which normally entails a prepaid expense in the balance sheet over the term of the agreement. Midsona has analysed whether the IFRIC clarifications for reporting cloud-based service arrangements would have any impact on the financial statements. The analysis resulted in the current management being in all material respects consistent with the principles regarding SaaS set out in the agenda decisions and in IAS 38 Intangible assets.

ments, as well as estimates made that could entail significant adjustments to subsequent financial statements, please refer to Note 35 Important estimates and assessments on page 162 of the 2021 Annual Report.

No new significant estimates and assessments have been added since the publication of the most recent annual report.

Note 3 | Operating segments, Group

SEK million Nordics North Europe South Europe Group-wide
functions
Group
April–June 2022 2021 2022 2021 2022 2021 2022 2021 2022 2021
Net sales, external 654 605 208 199 94 99 956 903
Net sales, intra-Group 3 1 7 5 2 1 –12 –7
Net sales 657 606 215 204 96 100 –12 –7 956 903
Expenses for goods sold –472 –410 –184 –165 –87 –76 12 5 –731 –646
Gross profit 185 196 31 39 9 24 0 –2 225 257
Other operating expenses –163 –153 –37 –21 –20 –18 –18 –23 –238 –215
Operating profit 22 43 –6 18 –11 6 –18 –25 –13 42
Financial items –14 –12
Profit before tax –27 30
Significant income and expense items reported in the income
statement:
Items affecting comparability¹ 4 –1 1 –10 1 8 6 –3
Depreciation/amortisation and impairment 13 14 11 11 5 4 12 18 41 47
Gross profit, before items affecting comparability 185 195 31 39 10 24 0 –2 226 256
Operating profit, before items affecting comparability 26 42 –5 8 –10 6 –18 –17 –7 39
EBITDA, before items affecting comparability 39 56 6 19 –5 10 –6 –7 34 78
Average number of employees 452 436 221 225 148 150 17 17 838 828
Number of employees as per the balance sheet date 443 440 214 228 153 151 16 17 826 836

1 For a specification of items affecting comparability, refer to the definitions and reconciliations against IFRS, Group, on pages 18–19.

SEK million Nordics North Europe South Europe Group-wide
functions
Group
January–June 2022 2021 2022 2021 2022 2021 2022 2021 2022 2021
Net sales, external 1,308 1,259 428 415 192 194 1,928 1,868
Net sales, intra-Group 6 6 9 13 4 3 –19 –22
Net sales 1,314 1,265 437 428 196 197 –19 –22 1,928 1,868
Expenses for goods sold –930 –859 –371 –347 –166 –150 18 20 –1,449 –1,336
Gross profit 384 406 66 81 30 47 –1 –2 479 532
Other operating expenses –322 –303 –74 –55 –41 –37 –33 –41 –470 –436
Operating profit 62 103 –8 26 –11 10 –34 –43 9 96
Financial items –22 –23
Profit before tax –13 73
Significant income and expense items reported in the income
statement:
Items affecting comparability¹ 4 –1 1 –10 1 10 6 –1
Depreciation/amortisation and impairment 26 27 22 21 11 9 22 28 81 85
Gross profit, before items affecting comparability 384 405 66 81 31 47 –1 –2 480 531
Operating profit, before items affecting comparability 66 102 –7 16 –10 10 –34 –33 15 95
EBITDA, before items affecting comparability 92 129 15 37 1 19 –12 –13 96 172
Average number of employees 455 444 222 220 145 150 18 16 840 830
Number of employees as per the balance sheet date 443 440 214 228 153 151 16 17 826 836

1 For a specification of items affecting comparability, refer to the definitions and reconciliations against IFRS, Group, on pages 18–19.

Note 4 | Breakdown of income, Group

SEK million Nordics North Europe South Europe Group-wide
functions
Group
April–June 2022 2021 2022 2021 2022 2021 2022 2021 2022 2021
Geographical areas¹
Sweden 284 278 0 0 1 0 –2 –1 283 277
Denmark 139 126 4 5 1 0 –5 –3 139 128
Finland 101 69 0 0 101 69
Norway 107 105 0 0 0 0 0 0 107 105
France 0 0 5 5 51 58 –3 –2 53 61
Spain 2 3 5 3 36 35 0 43 41
Germany 2 1 180 168 0 0 –2 –1 180 168
Rest of Europe 21 21 21 23 4 3 46 47
Other countries outside Europe 1 3 0 0 3 4 4 7
Net sales 657 606 215 204 96 100 –12 –7 956 903
Sales channel
Pharmacies 117 95 117 95
Grocery trade 412 396 88 89 34 30 534 515
Food Service 25 21 65 58 2 1 92 80
Healthfood stores 38 34 50 47 47 55 135 136
Other specialist retailers 30 30 5 4 35 34
Others 32 28 0 1 11 14 43 43
Group-internal sales 3 2 7 5 2 0 –12 –7
Net sales 657 606 215 204 96 100 –12 –7 956 903
Product categories
Organic products 168 176 215 204 95 100 –12 –7 466 473
Healthfoods 276 261 276 261
Consumer health products 209 167 209 167
Services linked to product handling 4 2 0 0 1 0 0 0 5 2
Net sales 657 606 215 204 96 100 –12 –7 956 903
Brands
Own 457 437 135 129 71 80 –12 –7 651 639
Licensed 140 111 8 8 148 119
Contract manufacture 56 56 80 75 16 12 152 143
Services linked to product handling 4 2 0 0 1 0 0 0 5 2
Net sales 657 606 215 204 96 100 –12 –7 956 903

1 Income from external customers is attributable to individual geographical areas according to the country in which the customer is domiciled.

Spanish brand Vegetalia launched new vegan products during the quarter.

SEK million Nordics North Europe South Europe Group-wide
functions
Group
January–June 2022 2021 2022 2021 2022 2021 2022 2021 2022 2021
Geographical areas¹
Sweden 561 563 0 0 2 1 –3 –2 560 562
Denmark 267 277 6 11 1 1 –6 –10 268 279
Finland 209 141 0 0 209 141
Norway 218 223 0 0 1 0 –1 0 218 223
France 1 2 10 11 106 111 –4 –4 113 120
Spain 5 7 9 6 73 71 0 87 84
Germany 4 5 367 352 1 1 –5 –6 367 352
Rest of Europe 46 44 45 48 6 5 97 97
Other countries outside Europe 3 3 0 0 6 7 9 10
Net sales 1,314 1,265 437 428 196 197 –19 –22 1,928 1,868
Sales channel
Pharmacies 217 182 217 182
Grocery trade 826 838 183 190 64 55 1,073 1,083
Food Service 47 39 128 109 3 2 178 150
Healthfood stores 82 75 107 105 101 111 290 291
Other specialist retailers 64 61 10 9 74 70
Others 72 64 0 2 24 26 96 92
Group-internal sales 6 6 9 13 4 3 –19 –22
Net sales 1,314 1,265 437 428 196 197 –19 –22 1,928 1,868
Product categories
Organic products 354 396 437 428 195 197 –18 –22 968 999
Healthfoods 550 529 550 529
Consumer health products 403 336 403 336
Services linked to product handling 7 4 0 0 1 0 –1 0 7 4
Net sales 1,314 1,265 437 428 196 197 –19 –22 1,928 1,868
Brands
Own 929 912 272 265 148 156 –18 –22 1,331 1,311
Licensed 265 233 17 16 282 249
Contract manufacture 113 116 165 163 30 25 308 304
Services linked to product handling 7 4 0 0 1 0 –1 0 7 4
Net sales 1,314 1,265 437 428 196 197 –19 –22 1,928 1,868

1 Income from external customers is attributable to individual geographical areas according to the country in which the customer is domiciled.

Note 5 | Assessment of financial assets and liabilities at fair value and categorisation

Fair value

The carrying amount on non-current receivables, accounts receivable, other receivables, cash and cash equivalents, other non-current receivables, accounts payable and other current liabilities constitutes a reasonable approximation of fair value.

Certain disclosures regarding financial instruments assessed at fair value through profit for the year

At the end of the period, the consolidated balance sheet included no financial instruments recognised at fair value. The comparison period included financial instruments in the form of currency swaps of SEK 0 million and currency futures of SEK 0 million recorded at fair value in the consolidated balance sheet. That valuation was at level 2, in accordance with IFRS 13 Fair Value Measurement. A market approach was used and fair value is based on brokers' listings. Similar contracts were traded on an active market and the rates reflected actual transactions on comparable instruments. The comparison period also included contingent purchase considerations that were recognised at fair value in the consolidated balance sheet. That valuation was at level 3, in accordance with IFRS 13 Fair Value Measurement. Fair value of conditional purchase considerations was calculated by discounting the present value of the expected cash flows with an adjusted discount rate. Expected cash flows were determined

based on likely scenarios for future gross profit, amounts that will be payable in the event of respective outcomes and the probability of the respective outcome.

Netting agreements and similar agreements

At the end of the period, the consolidated balance sheet included no financial instruments subject to netting agreements or similar. There were reported financial liabilities attributable to derivative instruments of SEK 0 million in the consolidated balance sheet for the comparison period, which were covered by a legally binding framework agreement on netting.

Calculation of fair value

Fair value of interest bearing liabilities is calculated based on future cash flows of principal and interest discounted at the current market rate on the balance sheet date. Long-term interest-bearing liabilities essentially mature at variable interest rates and therefore correspond essentially to fair value with a carrying amount. For current interest-bearing liabilities, no discount is applied and the fair value corresponds, in all material respects, to the carrying amount. For further information on the valuation of financial assets and liabilities, refer to Note 34 Valuation of financial assets and liabilities at fair value and the category breakdown on pages 160–161 in the 2021 Annual Report.

Note 6 | Change in number of shares, Group

Series A shares Series B shares Total
755,820 64,248,788 65,004,608
213,180 213,180
755,820 64,461,968 65,217,788
755,820 64,461,968 65,217,788
7,496,252 7,496,252
–457,500 457,500
298,320 72,415,720 72,714,040
298,320 72,415,720 72,714,040
298,320 72,415,720 72,714,040
5.00
363,570,200
75,398,920

Average number of shares, Group

Number of shares (thousands) Apr–Jun 2022 Apr–Jun 2021 Jan–Jun 2022 Jan–Jun 2021 Rolling 12-month Full year 2021
Average during the period 72,714 65,218 72,714 65,183 71,548 67,783
Average during the period, after full dilution 72,714 65,367 72,714 65,333 71,623 67,932

Two warrant programmes were outstanding at the end of the period, the TO2019/2022 series, which can provide a maximum of 150,960 new Series B shares on full conversion, and the TO2021/2024 series, which can provide a maximum of 171,000 new Series B shares on full conversion. Because the average price for Series B shares exceeded the subscription price for

TO2019/2022 and TO2021/2024 on the balance sheet date, earnings per share after dilution were not calculated. For more information on TO 2019/2022 and TO2021/2024, see Note 10 Employees, personnel expenses and senior executives' remuneration in the 2021 annual report, pages 146‒148.

The Urtekram brand expanded its Sweet Ginger Flower range with Anti-Dandruff shampoo and conditioner.

Definitions

Midsona presents certain financial measures in the Interim Report that are not defined under IFRS. Midsona considers these measures to provide useful supplemental information to investors and the company's management as they facilitate the evaluation of the company's performance. Because not all companies calculate financial measures in the same way, these are not always comparable to the measures used by other companies. Accordingly, these financial measures should not be considered a substitute for measurements as defined under IFRS. For the definition and purpose of respective measures not defined under IFRS, please see the definitions section on pages 184–188 in the 2021 Annual Report. The following table presents reconciliations against IFRS.

IFRS reconciliations, Group

EBITDA. Operating profit before amortisation/depreciation and impairment of tangible and intangible assets

SEK million Apr–Jun
2022
Apr–Jun
2021
Jan–Jun
2022
Jan–Jun
2021
Rolling
12-month
Full year
2021
Operating profit, before items affecting comparability –7 39 15 95 77 157
Items affecting comparability included in operating profit 1,2 –6 3 –6 1 –3 4
Operating profit –13 42 9 96 74 161
Amortisation of intangible assets 12 12 24 23 48 47
Impairment of intangible assets 8 8 8
Depreciation of tangible assets 29 27 57 54 112 109
Impairment of tangible fixed assets 4 4
EBITDA 28 89 90 181 238 329
Items affecting comparability included in EBITDA 1,2 6 –11 6 –9 –1 –16
EBITDA, before items affecting comparability 34 78 96 172 237 313
Net sales 956 903 1,928 1,868 3,833 3,773
EBITDA-margin, before items affecting comparability 3.6% 8.6% 5.0% 9.2% 6.2% 8.3%
1
Specification of items affecting comparability
Restructuring expenses, net
6
–1
6
–1
7
Revaluation of conditional purchase consideration

–10

–10
–11
Acquisition-related expenses



2
3
Impairment of intangible and tangible assets

8

8
4
Items affecting comparability included in operating profit
6
–3
6
–1
3
Impairment of intangible and tangible assets

–8

–8
–4
SEK million Apr–Jun 2022 Apr–Jun 2021 Jan–Jun 2022 Jan–Jun 2021 Rolling 12–month Full year 2021
0
–21
5
12
–4
–12
Items affecting comparability included in EBITDA 6 –11 6 –9 –1 –16

2 Corresponding line in the consolidated income statement

SEK million Apr–Jun 2022 Apr–Jun 2021 Jan–Jun 2022 Jan–Jun 2021 Rolling 12–month Full year 2021
Expenses for goods sold 1 –1 1 –1 6 4
Selling expenses 4 8 4 8 4 8
Administrative expenses 1 0 1 0 1 0
Other operating income –10 –10 –11 –21
Other operating expenses 0 2 3 5
Items affecting comparability included in operating profit 6 –3 6 –1 3 –4
Expenses for goods sold –4 –4
Selling expenses –8 –8 –8
Items affecting comparability included in EBITDA 6 –11 6 –9 –1 –16

Adjusted EBITDA. EBITDA, rolling 12 months pro forma, excluding acquisition-related restructuring and transaction expenses

SEK million Rolling
12-month
Full year
2021
EBITDA 238 329
Acquisition-related transaction expenses –8 –16
Pro forma adjustment 5 11
Adjusted EBITDA 235 324

Net debt. Interest-bearing provisions and interest-bearing liabilities less cash and cash equivalents, including short-term investments

SEK million 30 Jun 2022 30 Jun 2021 31 Dec 2021
Non-current interest-bearing liabilities 1,283 1,592 1,314
Current interest-bearing liabilities 233 210 175
Cash and cash equivalents ¹ –64 –86 –53
Net debt 1,452 1,716 1,436

¹ There were no short-term investments equivalent to cash and cash equivalents at the end of the respective period.

Average capital employed. Total equity and liabilities less interest-bearing liabilities and deferred tax liability at the end of the period plus total shareholders' equity and liabilities less interest-bearing liabilities and deferred tax liability at the beginning of the period divided by 2

SEK million Apr–Jun
2022
Apr–Jun
2021
Jan–Jun
2022
Jan–Jun
2021
Rolling
12-month
Full year
2021
Shareholders' equity and liabilities 5,423 5,157 5,423 5,157 5,423 5,287
Other non-current liabilities –11 –14 –11 –14 –11 –11
Deferred tax liabilities –352 –338 –352 –338 –352 –347
Accounts payable –372 –397 –372 –397 –372 –342
Other current liabilities –50 –101 –50 –101 –50 –56
Accrued expenses and deferred income –191 –184 –191 –184 –191 –167
Capital employed 4,447 4,123 4,447 4,123 4,447 4,364
Capital employed at the beginning of the period 4,445 4,162 4,364 4,092 4,123 4,092
Average capital employed 4,446 4,143 4,406 4,108 4,285 4,228

Return on capital employed. Profit before tax plus financial expenses in relation to average capital employed

SEK million Rolling
12-month
Full year
2021
Profit before tax 29 115
Financial expenses 89 57
Profit before taxes, excluding financial expenses 118 172
Average capital employed 4,285 4,228
Return on capital employed, % 2.8 4.1

Free cash flow. Cash flow from operating activities less cash flow from investing activities, excluding acquisitions/sales of operations, acquisitions/sales of trademarks and product rights and expansion investments

SEK million Apr–Jun
2022
Apr–Jun
2021
Jan–Jun
2022
Jan–Jun
2021
Rolling
12-month
Full year
2021
Cash flow from operating activities 54 –29 46 –48 30 –64
Cash flow from investing activities –4 –20 –14 –35 –154 –175
Acquisitions of companies or operations 3 3 111 114
Expansion investment, new production line 3 11 6 19 18 31
Free cash flow 53 –35 38 –61 5 –94

Organic change, net sales. Net change in sales between years adjusted for translation effects on consolidation and for changes in the Group structure

SEK million Apr–Jun
2022
Apr–Jun
2021
Jan–Jun
2022
Jan–Jun
2021
Rolling
12-month
Full year
2021
Net sales 956 903 1,928 1,868 3,833 3,773
Net sales compared with the corresponding period in the previous year –903 –859 –1,868 –1,805 –3,772 –3,709
Net sales, change 53 44 60 63 61 64
Structural changes –27 –104 –61 –210 –206 –355
Exchange rate changes –23 24 –50 58 –41 67
Organic change 3 –36 –51 –89 –186 –224
Organic change 0.4% –4.2% –2.7% –4.9% –4.9% –6.0%
Structural changes 3.0% 12.1% 3.3% 11.6% 5.5% 9.5%
Exchange rate changes 2.5% –2.8% 2.6% –3.2% 1.1% –1.8%

Organic change in net sales of own brands. Net change in sales of own brands between years adjusted for translation effects on consolidation and for changes in the Group structure

Apr–Jun Apr–Jun Jan–Jun Jan–Jun Rolling Full year
SEK million 2022 2021 2022 2021 12-month 2021
Net sales own brands 652 639 1,331 1,311 2,642 2,622
Net sales own brands compared with the corresponding period in the previous year –639 –599 –1,311 –1,252 –2,609 –2,550
Net sales own brands, change 13 40 20 59 33 72
Structural changes –13 –55 –31 –111 –111 –191
Exchange rate changes –15 16 –32 39 –26 45
Organic change own brands –15 1 –43 –13 –104 –74
Organic change –2.3% 0.2% –3.3% –1.0% –4.0% –2.9%
Structural changes 2.0% 9.3% 2.4% 8.9% 4.3% 7.5%
Exchange rate changes 2.3% –2.7% 2.4% –3.1% 1.0% –1.8%

Quarterly data

SEK million 2022
Q2
2022
Q1
2021
Q4
2021
Q3
2021
Q2
2021
Q1
2020
Q4
2020
Q3
2020
Q2
2020
Q1
2019
Q4
2019
Q3
Net sales 956 972 1,012 893 903 965 1,083 821 859 946 825 765
Expenses for goods sold –731 –718 –770 –652 –646 –690 –784 –598 –619 –671 –594 –524
Gross profit 225 254 242 241 257 275 299 223 240 275 231 241
Selling expenses –162 –157 –148 –138 –155 –151 –161 –128 –123 –130 –129 –122
Administrative expenses –76 –74 –76 –67 –73 –73 –88 –60 –70 –66 –64 –56
Other operating income 2 2 3 12 13 7 17 16 17 2 30 –1
Other operating expenses –2 –3 –4 0 0 –4 –1 –4 9 –10 –16 –5
Operating profit –13 22 17 48 42 54 66 47 73 71 52 57
Result from participations in joint ventures –8 0 –1
Financial income 25 10 5 4 –5 7 7 3 –29 33 0 0
Financial expenses –39 –18 –16 –16 –7 –18 –22 –10 16 –43 –9 –13
Profit before tax –27 14 6 36 30 43 51 40 52 61 42 44
Tax on profit for the period 7 –2 –5 –5 –6 –10 4 –6 –12 –14 –7 –9
Profit for the period –20 12 1 31 24 33 55 34 40 47 35 35
Items affecting comparability
Items affecting comparability included in operating profit 6 3 –6 –3 2 7 –10 –11 –5 –8
Operating profit, before items affecting comparability –7 22 20 42 39 56 73 37 62 71 47 49
Depreciation/amortisation and impairment
Depreciation/amortisation and impairment included in
operating income
41 40 41 42 47 38 41 35 35 36 34 28
EBITDA 28 62 58 90 89 92 107 82 108 107 86 85
Depreciation/amortisation, impairment and items
affecting comparability
Depreciation/amortisation, impairment and items
affecting comparability included in operating profit
47 40 44 32 36 40 48 25 24 36 29 20
EBITDA, before items affecting comparability 34 62 61 80 78 94 114 72 97 107 81 77
Free cash flow 53 –15 –25 –8 –35 –26 102 64 84 2 103 19
Cash flow from operating activities 54 –8 –16 0 –29 –19 113 71 89 10 117 29
Number of employees as per the balance sheet date 826 859 849 819 836 831 834 723 730 713 721 571

Exchange rates

Average exchange rate Closing day rate
SEK Jan–Jun 2022 Jan–Jun 2021 Jan‒Dec 2021 30 Jun 2022 30 Jun 2021 31 Dec 2021
DKK 1.4083 1.3619 1.3641 1.4356 1.3616 1.3753
EUR 10.4787 10.1281 10.1449 10.6801 10.1249 10.2269
GBP 12.4427 11.6718 11.8022 12.4127 11.7663 12.1790
NOK 1.0504 0.9956 0.9980 1.0314 0.9942 1.0254
USD 9.5856 8.4039 8.5815 10.2194 8.5103 9.0437

Midsona AB (publ)

Corporate identity number: 556241-5322 Visitors: Dockplatsen 16, Malmö, Sweden Postal address: Box 210 09, SE-200 21 Malmö, Sweden Telephone: +46 40 601 82 00 E-mail: [email protected] www.midsona.com